ArticleBMC infectious diseases2024

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.

Kyle C Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.